We are live on ! Find out more
GD

Grandfield & Dodd Portfolio holdings

AUM $1.77B
1-Year Est. Return 23.43%
This Fund
S&P 500
This Quarter Est. Return
-1.72%
1 Year Est. Return
+23.43%
3 Year Est. Return
+55.25%
5 Year Est. Return
+78.92%
10 Year Est. Return
+317.48%
AUM
$896M
AUM Growth
-$40.3M
Cap. Flow
-$18.6M
Cap. Flow %
-2.07%
Top 10 Hldgs %
28.01%
Holding
188
New
5
Increased
33
Reduced
88
Closed
11

Top Buys

Rank Stock Value
1
WPP icon
WPP
WPP
+$3.66M
2
PPG icon
PPG Industries
PPG
+$2.14M
3
NTR icon
Nutrien
NTR
+$1.9M
4
WY icon
Weyerhaeuser
WY
+$1.04M
5
USB icon
US Bancorp
USB
+$1.01M

Top Sells

Rank Stock Value
1
COL
Rockwell Collins
COL
+$4.88M
2
XRAY icon
Dentsply Sirona
XRAY
+$4.24M
3
VOD icon
Vodafone
VOD
+$3.54M
4
MSFT icon
Microsoft
MSFT
+$2.91M
5
AGU
Agrium
AGU
+$1.96M

Sector Composition

Rank Sector Weight
1 Technology 22.7%
2 Healthcare 16.8%
3 Industrials 10.59%
4 Financials 10.31%
5 Consumer Staples 10.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FAST icon
101
Fastenal
FAST
$55.2B
$854K 0.1%
62,540
REGN icon
102
Regeneron Pharmaceuticals
REGN
$72.9B
$842K 0.09%
2,445
+711
+41% +$247K
BA icon
103
Boeing
BA
$175B
$824K 0.09%
2,513
-305
-11% -$103K
MO icon
104
Altria Group
MO
$125B
$795K 0.09%
12,763
NBL
105
DELISTED
Noble Energy, Inc.
NBL
$753K 0.08%
24,849
RDS.A
106
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$711K 0.08%
11,139
WFC icon
107
Wells Fargo
WFC
$263B
$695K 0.08%
13,252
-4,937
-27% -$293K
V icon
108
Visa
V
$697B
$683K 0.08%
5,707
-138
-2% -$16.7K
ISRG icon
109
Intuitive Surgical
ISRG
$130B
$665K 0.07%
4,833
SLB icon
110
SLB Ltd
SLB
$74.2B
$661K 0.07%
10,198
-500
-5% -$34.9K
INCY icon
111
Incyte
INCY
$26B
$652K 0.07%
7,823
-120
-2% -$10.8K
NBIX icon
112
Neurocrine Biosciences
NBIX
$18.4B
$634K 0.07%
7,645
-270
-3% -$22.8K
GLD icon
113
SPDR Gold Trust
GLD
$131B
$629K 0.07%
5,000
-727
-13% -$91.7K
FUL icon
114
H.B. Fuller
FUL
$3.07B
$601K 0.07%
12,094
IONS icon
115
Ionis Pharmaceuticals
IONS
$9.14B
$590K 0.07%
13,389
-280
-2% -$14.2K
SGEN
116
DELISTED
Seagen Inc. Common Stock
SGEN
$576K 0.06%
11,006
-350
-3% -$19.1K
FISV
117
Fiserv Inc
FISV
$28.9B
$535K 0.06%
7,502
BMRN icon
118
BioMarin Pharmaceuticals
BMRN
$12B
$531K 0.06%
6,547
-240
-4% -$20.6K
CSX icon
119
CSX Corp
CSX
$94.2B
$518K 0.06%
27,900
OMC icon
120
Omnicom Group
OMC
$24.6B
$517K 0.06%
7,111
AMZN icon
121
Amazon
AMZN
$2.48T
$515K 0.06%
7,120
-1,040
-13% -$74.4K
FTV icon
122
Fortive
FTV
$19.5B
$509K 0.06%
10,406
T icon
123
AT&T
T
$169B
$504K 0.06%
18,728
-1,703
-8% -$47.4K
LLY icon
124
Eli Lilly
LLY
$1.09T
$490K 0.05%
6,333
VEU icon
125
Vanguard FTSE All-World ex-US ETF
VEU
$65.6B
$487K 0.05%
8,950

Similar funds

Grandfield & Dodd's Q1 2018 Portfolio in Review

As of Q1 2018, Grandfield & Dodd held 188 positions worth $896M, down 4.3% from $937M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Grandfield & Dodd's Q1 2018 filing shows 5 new, 33 increased, 88 reduced and 11 closed positions. Its largest new stake was Nutrien: 37,980 shares worth $1.79M. The largest sale was Rockwell Collins, an estimated $4.88M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Industrials.

  • Grandfield & Dodd's largest Q1 2018 buy was Nutrien: 37,980 shares worth $1.79M.
  • Grandfield & Dodd added most to WPP in Q1 2018, an estimated $3.66M increase.
  • Grandfield & Dodd's biggest Q1 2018 reduction was Rockwell Collins, cutting an estimated $4.88M.
  • Grandfield & Dodd fully exited Agrium in Q1 2018, selling an estimated $1.96M.
  • Grandfield & Dodd's ten largest holdings make up 28% of its $896M portfolio in Q1 2018.
  • Grandfield & Dodd opened 5 new positions and closed 11 in Q1 2018.
  • Grandfield & Dodd's portfolio value fell 4.3% quarter-over-quarter to $896M.

Based on Grandfield & Dodd's 13F filing for Q1 2018, filed 4 May 2018.